DK0525502T3 - Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinopløsninger - Google Patents

Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinopløsninger

Info

Publication number
DK0525502T3
DK0525502T3 DK92111947.5T DK92111947T DK0525502T3 DK 0525502 T3 DK0525502 T3 DK 0525502T3 DK 92111947 T DK92111947 T DK 92111947T DK 0525502 T3 DK0525502 T3 DK 0525502T3
Authority
DK
Denmark
Prior art keywords
preparation
virus inactivated
immunoglobulin solutions
inactivated immunoglobulin
solutions
Prior art date
Application number
DK92111947.5T
Other languages
English (en)
Other versions
DK0525502T4 (da
Inventor
Werner Gehringer
Patrick Selosse
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6437560&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0525502(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of DK0525502T3 publication Critical patent/DK0525502T3/da
Application granted granted Critical
Publication of DK0525502T4 publication Critical patent/DK0525502T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92111947T 1991-08-02 1992-07-14 Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinoplösninger DK0525502T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125625A DE4125625C2 (de) 1991-08-02 1991-08-02 Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen

Publications (2)

Publication Number Publication Date
DK0525502T3 true DK0525502T3 (da) 1997-03-17
DK0525502T4 DK0525502T4 (da) 2005-09-19

Family

ID=6437560

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92111947T DK0525502T4 (da) 1991-08-02 1992-07-14 Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinoplösninger

Country Status (14)

Country Link
US (1) US5648472A (da)
EP (1) EP0525502B2 (da)
JP (1) JP2969310B2 (da)
KR (1) KR100188448B1 (da)
AT (1) ATE143812T1 (da)
CZ (1) CZ291813B6 (da)
DE (2) DE4125625C2 (da)
DK (1) DK0525502T4 (da)
ES (1) ES2092604T5 (da)
FI (1) FI107122B (da)
IL (1) IL102525A (da)
SK (1) SK280680B6 (da)
YU (1) YU48242B (da)
ZA (1) ZA925764B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
AT403477B (de) * 1996-04-30 1998-02-25 Immuno Ag Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
US6159471A (en) † 1997-10-23 2000-12-12 Yoshitomi Pharmaceutical Industries, Ltd. Room temperature storable immunoglobulin preparation for intravenous injection
DE10016877A1 (de) * 2000-04-05 2001-10-18 Scintec Diagnostics Gmbh Zug (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
AU2003246829A1 (en) 2002-02-19 2003-09-09 Resolution Chemicals Limited Solvent-based sterilisation of pharmaceuticals
BRPI0412835A (pt) * 2003-08-12 2006-09-26 Octapharma Ag processo para preparação de uma solução de alfa-1-antitripsina
US6881573B2 (en) * 2003-09-12 2005-04-19 Allan L. Louderback Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
KR101206788B1 (ko) 2004-02-27 2012-11-30 옥타파르마 아게 정제된, 바이러스 안전한 항체 제제를 제공하는 방법
FR2944281B1 (fr) * 2009-04-08 2011-07-29 Fabre Pierre Dermo Cosmetique Derives soufres de resorcinol, leur preparation et leurs utilisations cosmetiques
AU2018331357A1 (en) * 2017-09-18 2020-04-02 Bayer Healthcare Llc Methods of inactivation of viruses using N-methylglucamides and its Derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US4909940A (en) * 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography

Also Published As

Publication number Publication date
ES2092604T3 (es) 1996-12-01
DE59207324D1 (de) 1996-11-14
CZ236992A3 (en) 1993-02-17
EP0525502A1 (de) 1993-02-03
SK236992A3 (en) 1995-01-05
SK280680B6 (sk) 2000-06-12
EP0525502B2 (de) 2005-08-10
DE4125625C2 (de) 1999-12-02
CZ291813B6 (cs) 2003-06-18
YU48242B (sh) 1997-08-22
JPH05202100A (ja) 1993-08-10
IL102525A0 (en) 1993-01-14
DE4125625A1 (de) 1993-02-04
KR100188448B1 (ko) 1999-06-01
US5648472A (en) 1997-07-15
ZA925764B (en) 1993-04-28
YU74092A (sh) 1995-10-24
KR930004329A (ko) 1993-03-22
EP0525502B1 (de) 1996-10-09
ATE143812T1 (de) 1996-10-15
ES2092604T5 (es) 2006-03-01
IL102525A (en) 2005-05-17
FI923425A0 (fi) 1992-07-29
FI107122B (fi) 2001-06-15
JP2969310B2 (ja) 1999-11-02
DK0525502T4 (da) 2005-09-19
FI923425A (fi) 1993-02-03

Similar Documents

Publication Publication Date Title
DK0525502T4 (da) Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinoplösninger
DK0725824T3 (da) Immunodominante humane T-celleepitoper af hepatitis C virus
DK373188A (da) Fremgangsmaade til opretning af fotomaskiner, navnlig foto-litografiske masker paa flade arbejdsstykker
HU9301794D0 (en) Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament
EP0128522A3 (en) High titer cytomegalovirus immune serum globulin and method of making same
DK422589D0 (da) Farmaceutisk praeparat til behandling af immundefekttilstande
DE69332045T2 (de) Hepatistherapeutikum
BR0010815A (pt) Método de preparação de globulina imune duplamente inativada viralmente para administração intravenosa
FI915813A0 (fi) Menetelmä luonnollisesti tuotetun kymosiinin talteenottamiseksi
PH31116A (en) Methods for the treatment of infection caused by hepatitis B virus (hbv).
ATE193287T1 (de) Herstellung von derivaten von a-acetyl neuraminicsäuren
DK0472708T3 (da) Fremgangsmåde til fremstilling af ikke-infektiøst blodplasma
ES8304431A1 (es) "un metodo para preparar una inmunoglobulina adecuada para administracion intravenosa".
ATE179428T1 (de) Verfahren zur herstellung von hepatitis antigenen und impfstoffen
DK373489A (da) Rekombinante hybrid-partikler med morphologiske egenskaber svarende til antigenet hbsag og omfattende en immunogen sekvens, der inducerer neutraliserende antistoffer rettet mod hiv-retrovirus eller som kan genkendes af saadanne antistoffer, samt vaccine paa basis af saadanne partikler
EP0571771A3 (en) Method of inactivation of viruses in proteinic preparations
DK78990D0 (da) Fremgangsmaade til rensning af ydre membran protein for haemophilus influenza
IT8621230A1 (it) Policarbonati ramificati contenenti acidi alifatici policarbossilici o loro derivati e procedimento per la loro preparazione
ATE164594T1 (de) Verfahren zur extraktion und reinigung von alpha- 1-antitrypsin (alpha 1-pi) aus cohnischer fraktion iv-1
DK0841954T3 (da) Fremgangsmåde til fremstilling af et virussikkert, terapeutisk, biologisk apparat
DK0589348T3 (da) Fremgangsmåde til immunkemisk kvantificering af inaktiverede, immunreaktive antigener
RO102195A2 (ro) Metoda si dispozitiv de prefiltrare a solutiei de concentrat a inhibitorului c1 esterazici